FAKTOR-OPTIONSSCHEIN - RECORDATI INDUSTRIA CHIMICA E FARMA | Real-time Bid/Ask 03:25:07 2024-06-05 am EDT | ||
| 7.32 EUR / 7.38 EUR | +2.94% |
|
| Current month | -0.56% | ||
| 1 month | -18.03% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
RECORDATI
| Date | Price | Change |
|---|---|---|
| 24-06-04 | 7.14 | +1.42% |
| 24-06-03 | 7.04 | -1.95% |
| 24-05-31 | 7.18 | +7.97% |
| 24-05-30 | 6.65 | -1.92% |
| 24-05-29 | 6.78 | -6.74% |
Delayed Quote Börse Stuttgart
Last update June 04, 2024 at 02:37 pm EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | RECORDATI |
| Issuer | Morgan Stanley |
| WKN | MG0HJY |
| ISIN | DE000MG0HJY3 |
| Date issued | 2024-03-20 |
| Strike | 36.16 € |
| Maturity | Unlimited |
| Parity | 1.71 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 10.67 € |
|---|---|
| Lowest since issue | 6.64 € |
| Spread | -0.02 € |
| Spread % | 0.28% |
Company Profile
Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- pharmaceutical and OTC products (67.9%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.;
- medicines for rare diseases (32.1%).
Net sales are distributed geographically as follows: Italy (15%), Europe (58.5%), America (17.5%), Australasia (6.2%) and Africa (2.8%).
Sector
-
Consensus: Recordati
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
48.2
EUR
Average target price
52.64
EUR
Spread / Average Target
+9.21%
- Stock Market
- Certificates
- Certificat
